Development of therapeutic peptide producers based on <i>Escherichia coli</i> BL21 and their cultivation technology

Introduction. Peptides with a molecular weight of less than 5 kDa have been used in medicine and biotechnology over the past decade for the treatment of various diseases. However, chemical synthesis peptide has several disadvantages, including low yield, reduced efficiency, and high costs. An altern...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Z. R. Khasanshina, I. A. Kornakov, E. A. Buslaeva, A. V. Kazakova, S. A. Ishchuk, V. I. Shmurak, V. B. Saparova, V. F. Latypov, R. V. Drai
Format: Artigo
Langue:Russo
Publié: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2025-03-01
Collection:Разработка и регистрация лекарственных средств
Sujets:
peptides
<i>escherichia coli</i>
design of experiments
cultivation
ulp
hplc-ms
Accès en ligne:https://www.pharmjournal.ru/jour/article/view/2023
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires